Simpson Thacher recently represented the underwriters, led by Barclays Capital Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC, in connection with a registered offering of $5 billion in notes by Pfizer Inc. The notes were issued in five series with maturities ranging from 2018 to 2044, with proceeds used for general corporate purposes, including the repayment of existing debt.
Pfizer is a research-based, global biopharmaceutical company. Pfizer’s global portfolio includes medicines, vaccines and medical devices, as well as many of the world’s best-known consumer healthcare products.
The Simpson Thacher team included Joe Kaufman, Jonathan Ozner and Meaghan Krupa (Capital Markets); Jon Cantor and Taylor Alexander (Tax); Lori Lesser and Marcela Robledo (Intellectual Property); Jamin Koslowe (Executive Compensation and Employee Benefits); Adeeb Fadil and Noreen Lavan (Environmental); and Andrew Pagliughi (FINRA and Blue Sky).